Brief: Lineage Provides Update On Patient Enrollment In Phase I/IIa Clinical Study of OpRegen

Lineage Cell Therapeutics

30/12/2019 13:13

Dec 30 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE PROVIDES UPDATE ON PATIENT ENROLLMENT IN PHASE
I/IIA
CLINICAL STUDY OF OPREGEN® FOR THE TREATMENT OF DRY AGE-RELATED
MACULAR DEGENERATION
    * LINEAGE CELL THERAPEUTICS - BASED ON EXISTING CASH,
CURRENT
VALUE OF MARKETABLE SECURITIES, CO TO ACHIEVE MILESTONES UNDER
REDUCED 2020 SPENDING PLAN

Source text for Eikon:  ID:nBw8MJfRza 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))